Share This Page
Drug Price Trends for TERBUTALINE SULFATE
✉ Email this page to a colleague
Average Pharmacy Cost for TERBUTALINE SULFATE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TERBUTALINE SULFATE 5 MG TAB | 62559-0722-01 | 1.11045 | EACH | 2025-04-23 |
| TERBUTALINE SULFATE 2.5 MG TAB | 00115-2611-01 | 1.18782 | EACH | 2025-04-23 |
| TERBUTALINE SULFATE 2.5 MG TAB | 00527-1318-01 | 1.18782 | EACH | 2025-04-23 |
| TERBUTALINE SULFATE 2.5 MG TAB | 62135-0524-90 | 1.18782 | EACH | 2025-04-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Terbutaline Sulfate
Introduction to Terbutaline Sulfate
Terbutaline sulfate is a beta-2 adrenergic agonist widely used in the treatment of respiratory conditions such as asthma, bronchospasm, and chronic obstructive pulmonary disease (COPD). It is also utilized in obstetric care to delay preterm labor. Here’s a comprehensive analysis of the market and price projections for terbutaline sulfate.
Market Size and Growth Projections
The terbutaline sulfate market has experienced rapid and substantial growth in recent years and is expected to continue this trend. From 2023 to 2031, the market is projected to grow at a remarkable CAGR, driven by increasing demand for effective treatments for respiratory illnesses and preterm labor[1][4].
- Forecast Period: The market is expected to expand significantly from 2024 to 2031, with robust growth rates anticipated throughout the forecast period.
- Market Segments: The market is segmented by type (injectable solution, oral tablet, syrup) and application (wheezing, shortness of breath, chest tightness, chronic bronchitis, emphysema, others), as well as by geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa)[1][4].
Key Drivers of Market Growth
Several factors are driving the growth of the terbutaline sulfate market:
- Rising Prevalence of Respiratory Conditions: The increasing incidence of asthma, COPD, and other respiratory diseases globally is a major driver. Terbutaline sulfate's effectiveness in providing quick relief from bronchial constriction makes it a crucial medication in managing these conditions[3].
- Obstetric Care: The use of terbutaline sulfate injections to delay preterm labor is another significant factor. These injections help prevent uterine contractions and extend pregnancy, which is a critical intervention in obstetric practice[3].
- Technological Advancements: Improvements in drug delivery technology enhance the safety, effectiveness, and patient compliance of terbutaline sulfate medications, further boosting market demand[3].
- Cost-Effectiveness: Terbutaline sulfate is more affordable compared to newer bronchodilators, making it an attractive option, especially in developing countries with limited healthcare funding. The availability of generic versions post-patent expiration also increases its accessibility[3].
Market Challenges and Restraints
Despite the positive growth trajectory, the terbutaline sulfate market faces several challenges:
- Regulatory Hurdles: Strict regulations governing medication approvals can impede market expansion. The availability of substitute therapies also poses a challenge[3].
- Emergence of New Treatments: The rise of newer, possibly longer-lasting bronchodilators could impact the demand for terbutaline sulfate. However, its quick action during acute asthma episodes maintains its relevance as a rescue drug[3].
Competitive Landscape
The competitive landscape of the terbutaline sulfate market is characterized by the presence of both established and emerging players. Key companies profiled in market reports include:
- Lusochimica SPA
- Deafarma
- Jayco Chemical Industries
- Melody Healthcare Pvt. Ltd.
- Supriya Life Science Limited
These companies are profiled based on the types of products they offer and various market-related factors, including their year of market entry[1][4].
Price Projections and Affordability
The price of terbutaline sulfate can vary significantly based on the form and region:
- Retail Price: On average, the retail price of terbutaline sulfate can be around $171.11, but it can be reduced to $38.99 with the use of coupons or discounts[5].
- Generic Versions: The availability of generic versions post-patent expiration is expected to further reduce prices, making the medication more accessible to a wider population[3].
Geographical Market Analysis
The terbutaline sulfate market is analyzed across various geographical regions:
- North America: This region is expected to be a significant market due to high healthcare spending and a large patient base suffering from respiratory conditions.
- Europe: Europe also represents a substantial market, driven by advanced healthcare infrastructure and high demand for respiratory treatments.
- Asia-Pacific: The Asia-Pacific region is anticipated to show rapid growth due to increasing healthcare expenditure and a rising prevalence of respiratory diseases.
- South America and Middle-East and Africa: These regions are also expected to contribute to market growth, particularly as healthcare access and awareness improve[1][4].
Market Outlook and Emerging Trends
The market outlook for terbutaline sulfate is positive, driven by several emerging trends:
- Increased Awareness: Growing awareness among patients and healthcare professionals about the benefits of prompt intervention and treatment for respiratory illnesses is driving demand.
- Technological Innovations: Advances in drug delivery technology are expected to enhance the safety and effectiveness of terbutaline sulfate, further boosting its market appeal[3].
Key Takeaways
- Rapid Market Growth: The terbutaline sulfate market is expected to grow significantly from 2023 to 2031.
- Key Drivers: Rising prevalence of respiratory conditions, use in obstetric care, technological advancements, and cost-effectiveness are major drivers.
- Challenges: Regulatory hurdles, emergence of new treatments, and strict laws governing medication approvals are challenges.
- Competitive Landscape: The market is characterized by both established and emerging players.
- Price Projections: Prices are expected to remain competitive, especially with the availability of generic versions.
FAQs
-
What are the primary applications of terbutaline sulfate?
- Terbutaline sulfate is primarily used to treat respiratory conditions such as asthma, bronchospasm, and COPD, as well as to delay preterm labor in obstetric care[3].
-
Which regions are expected to drive the growth of the terbutaline sulfate market?
- North America, Europe, and the Asia-Pacific region are expected to be significant drivers of market growth due to high healthcare spending and a large patient base[1][4].
-
What are the key factors driving the growth of the terbutaline sulfate market?
- The rising prevalence of respiratory conditions, use in obstetric care, technological advancements, and cost-effectiveness are key drivers[3].
-
How does the availability of generic versions impact the market?
- The availability of generic versions post-patent expiration is expected to increase market penetration and reduce prices, making the medication more accessible[3].
-
What challenges does the terbutaline sulfate market face?
- The market faces challenges such as regulatory hurdles, the emergence of new treatments, and strict laws governing medication approvals[3].
Sources
- Market Research Intellect - Global Terbutaline Sulfate Market Size, Trends and Projections
- Verified Market Reports - Terbutaline Sulfate Injection Market Size, Share, Trends & Growth
- Verified Market Reports - Terbutaline Sulfate Injection Market Size, Share, Trends & Growth
- Market Research Intellect - Terbutaline Sulfate Market Size, Scope And Forecast Report
- SingleCare - Terbutaline Sulfate Coupons & Prices
More… ↓
